Ropeginterferon alfa-2b increases complete hematologic response from 26% to 59% in polycythemia vera
Ropeginterferon alfa-2b shows promise for patients with polycythemia vera
This meta-analysis of 1,836 patients with myeloproliferative neoplasms found that ropeginterferon alfa-2b increases complete hematologic res…
New data shows ropeginterferon alfa-2b helps many patients with polycythemia vera achieve better blood counts and lower disease markers over…
12-week home exercise intervention shows LDH reduction and high feasibility in myeloproliferative neoplasms patients
Can a simple home workout help patients with blood disorders feel better and move more freely?
This randomized controlled pilot trial evaluated a 12-week home-based exercise program involving flexibility, resistance, and aerobics in 55…
A simple home workout helped patients with blood disorders feel better, move more freely, and reduced a marker of cell damage without any sa…